Guardant Health
GH
#2737
Rank
NZ$8.49 B
Marketcap
$68.87
Share price
-2.12%
Change (1 day)
115.53%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company